The role of phosphodiesterase inhibitors in heart failure
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 57 (2-3) , 161-170
- https://doi.org/10.1016/0163-7258(93)90054-h
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Intravenous milrinone: Therapeutic responses in heart failureAmerican Heart Journal, 1991
- Muscle blood flow during forearm exercise in patients with severe heart failure.Circulation, 1990
- Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patientsAmerican Heart Journal, 1987
- Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter studyJournal of the American College of Cardiology, 1987
- Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failureJournal of the American College of Cardiology, 1986
- Amrinone activates K+-depolarized atrial and ventricular myocardium of guinea pigs.Circulation Research, 1982
- Atrioventricular conduction disturbances during hypoxia. Possible role of adenosine in rabbit and guinea pig heart.Circulation Research, 1980
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- Cyclic Nucleotide Phosphodiesterases: Properties, Activators, Inhibitors, Structure–Activity Relationships, and Possible Role in Drug DevelopmentJournal of Pharmaceutical Sciences, 1975
- Influence of Caffeine and other Methylxanthines on Mechanical Properties of Isolated Mammalian Heart Muscle: EVIDENCE FOR A DUAL MECHANISM OF ACTIONCirculation Research, 1972